Results 101 to 110 of about 82,737 (218)

Psychiatric Safety of Tirzepatide in People With Obesity and No Known Major Psychopathology: A Post Hoc Analysis of SURMOUNT

Obesity, Volume 34, Issue 3, Page 565-578, March 2026.
ABSTRACT Objective This post hoc analysis assessed psychiatric changes with tirzepatide in adults with obesity, without known major psychopathology, from SURMOUNT‐1, SURMOUNT‐2, and SURMOUNT‐3. Methods In participants (N = 4056) treated with tirzepatide (5/10/15 mg or maximum tolerated dose 10/15 mg) versus placebo, depressive symptoms and suicidal ...
Thomas A. Wadden, Maria A. Oquendo, Robert F. Kushner, Dachuang Cao, Chrisanthi A. Karanikas, Afton Kechter, Madhumita A. Murphy   +6 more
wiley   +1 more source

Neuromyelitis optica - an update: 2007-2009

Annals of Indian Academy of Neurology, 2009
Neuromyelitis optica is an inflammatory demyelinating disorder of the central nervous system. The discovery of a specific antibody (NMO IgG /aquaporin-4 antibody) in patients with this condition has led to a marked revival of research on the disease ...
Jacob Anu
doaj  

Longitudinal Myelitis [PDF]

Mayo Clinic Proceedings, 2008
Nicole M, Orzechowski, Clement J, Michet
openaire   +2 more sources

A case of diverse psychiatric and functional impairments following immune checkpoint inhibitor therapy

Psychiatry and Clinical Neurosciences Reports, Volume 5, Issue 1, March 2026.
Abstract Background Immune checkpoint inhibitors (ICIs) can cause a range of immune‐related adverse events (irAEs), including rare neuropsychiatric complications. However, these events often present with diverse and non‐specific symptoms, making diagnosis difficult.
Takako Ikegami, Ryoichi Sadahiro, Junji Yamaguchi, Eri Nishikawa, Saho Wada, Tatsuto Terada, Rika Nakahara, Hiromichi Matsuoka   +7 more
wiley   +1 more source

Neuromyelitis optica

Annals of Indian Academy of Neurology, 2007
Neuromyelitis optica (NMO) or Devic′s disease was until recently regarded as an unusual or severe variant of multiple sclerosis. However the last decade has seen major advances in our understanding of the etiopathogenesis of NMO. Though unsettled,
Jacob Anu, Boggild Mike
doaj  

Bridging FDA Adverse Event Reporting System (FAERS) and Clinical Practice: Comprehensive Characterization of Immune Checkpoint Inhibitors Toxicities in Geriatric Lung Cancer Patients

Thoracic Cancer, Volume 17, Issue 6, March 2026.
Elderly lung cancer patients face increased risks of severe and fatal AEs during ICIs treatment. Reports concerning males, Asians, and anti‐PD‐1 recipients were associated with higher odds of a fatal outcome. Immune‐mediated pneumonitis is the most frequently reported severe AE, calling for heightened vigilance for these high‐risk subgroups.
Yumeng Tian, Xin Nie, Yue Yuan, Qian Wei, SiQi Zhang, Lin Li   +5 more
wiley   +1 more source

Efficacy and Safety of Rituximab Versus Inebilizumab in Patients With Neuromyelitis Optica Spectrum Disorder: A Dual‐Center, Real‐World Cohort Study

European Journal of Neurology, Volume 33, Issue 3, March 2026.
In our real‐world study of 276 patients, rituximab and inebilizumab demonstrated comparable efficacy in the medium term but differed in their safety profiles, with a significantly higher incidence of infusion‐related reactions observed in the rituximab group.
Ying Cui, Zihao Yu, Hengri Cong, Hao Zhang, Yutong Shi, Ai Guo, Yujing Li, Dongmei Jia, Chao Zhang, Kaibin Shi, Fu‐Dong Shi, Wei Jiang   +11 more
wiley   +1 more source

Case report: Acute HHV6B encephalitis/myelitis post CAR-T cell therapy in patients with relapsed/refractory aggressive B-cell lymphoma

Frontiers in Neurology
BackgroundThe development of chimeric antigen receptor (CAR)-T cell therapy has revolutionized treatment outcomes in patients with lymphoid malignancies.
Ningwen Li, Ningwen Li, Ruoxuan Zhang, Ruoxuan Zhang, Jue Wang, Jue Wang, Xiaojian Zhu, Xiaojian Zhu, Fankai Meng, Fankai Meng, Yang Cao, Yang Cao, Gaoxiang Wang, Gaoxiang Wang, Yang Yang, Yang Yang   +15 more
doaj   +1 more source

MOG antibody-associated disease – a new entity or one of the forms of the NMO spectrum?

Aktualności Neurologiczne, 2019
Myelin oligodendrocyte glycoprotein (MOG) is a protein involved in the maintenance of the myelin structure. Recent studies have shown that serum anti-MOG antibodies are found in some of the patients who meet the diagnostic criteria for neuromyelitis ...
Dominika Czarnecka, Mariusz Stasiołek
doaj   +1 more source

Multiple Mononeuropathy Secondary to Parvovirus B19 Infection: A Case Series

European Journal of Neurology, Volume 33, Issue 3, March 2026.
Parvovirus B19 infection can cause multiple mononeuropathy in young and immunocompetent patients, predominantly affecting sensory nerves, with frequent involvement of the median, fibular, and ulnar nerves, as well as occasional cranial nerve impairment.
Julian Theuriet, Maud Michaud, Guillaume Fargeot, Céline Labeyrie, Anaïs Grosset, Maude Bucy, Ludivine Kouton, Florian Hubben, Véronique Manel, Florent Cluse, Adrien Bohic, Nicolas Rodriguez, Philippe Petiot, Geneviève Billaud, Vincent Fabry, Pascal Cintas, Thierry Maisonobe, Karine Viala, Rabab Debs, Dimitri Psimaras, Sarah Leonard‐Louis, Benjamin Terrier, Alina Dorobat, Céline Tard, Stéphane Darteyre, Alex Vicino, Marie Théaudin, Clovis Adam, Françoise Bouhour, Timothée Lenglet, Grégory Destras, Nathalie Streichenberger, Antoine Pegat   +32 more
wiley   +1 more source